Discover the Cipla Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...

Cipla: The pharmaceutical company said that it will invest approximately ZAR 900 million (nearly Rs 417.93 crore) in equity share capital of wholly owned subsidiary Cipla Medpro South Africa ...

Mumbai: Cipla has announced that the Company will invest approx. ZAR 900 million in equity share capital of Cipla Medpro ...

Welcome to the Cipla Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock. Stay ...

Samvardhana Motherson, Garden Reach Shipbuilders, NLC India and Central Bank of India are also among the stocks to watch in ...

CMSA, is a wholly owned subsidiary of Cipla, and is the holding company for the group operations in South Africa. The group is involved in the manufacturing, marketing, and supply of pharmaceutical ...

Generic injectables maker Gland Pharma on February 3 reported a 7% rise in third-quarter profit, as lower expenses helped ...

Cipla Ltd is set to invest ZAR 900 million in its wholly-owned subsidiary, Cipla Medpro South Africa Proprietary Ltd. The ...

AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...

Budget 2025 boosts healthcare with Rs 98,311 crore allocation, expanding medical education and cancer care while easing drug costs. Pharma stocks gain momentum amid duty cuts and PLI incentives.

Positive vibes on the broader market indices have kept their upward momentum on the last day of January expiry, with gains ...

HYDERABAD/BENGALURU (Reuters) -Sun Pharmaceutical, India's largest drugmaker by revenue, reported a bigger-than-expected quarterly profit on Friday, aided by strong sales in the domestic market. The ...